Attached files

file filename
10-Q - 10-Q - STERIS plcste-20201231.htm
EX-32.1 - EX-32.1 - STERIS plcste12312020ex321.htm
EX-31.2 - EX-31.2 - STERIS plcste12312020ex312.htm
EX-31.1 - EX-31.1 - STERIS plcste12312020ex311.htm
EX-10.6 - EX-10.6 - STERIS plcste12312020exhibit106.htm
EX-10.5 - EX-10.5 - STERIS plcste12312020exhibit105.htm
EX-10.4 - EX-10.4 - STERIS plcste12312020exhibit104.htm
EX-10.3 - EX-10.3 - STERIS plcste12312020exhibit103.htm
EX-10.2 - EX-10.2 - STERIS plcste12312020exhibit102.htm

                                                Exhibit 15.1

LETTER REGARDING UNAUDITED INTERIM FINANCIAL INFORMATION


Shareholders and Board of Directors
STERIS plc
 
 
We are aware of the incorporation by reference in the following STERIS plc Registration Statements of our review report dated February 9, 2021 relating to the unaudited consolidated interim financial statements of STERIS plc and subsidiaries that are included in its Form 10-Q for the quarter ended December 31, 2020:

Registration
Number
 
Description
 
333-230557Form S-8 Registration Statement of STERIS plc pertaining to the STERIS Corporation 401(k) Plan
333-230558Form S-8 Registration Statement of STERIS plc pertaining to the STERIS plc 2006 Long-Term Equity Incentive Plan (As Assumed, Amended and Restated Effective March 28, 2019)


/s/ Ernst & Young LLP

Cleveland, Ohio
February 9, 2021